Management of diabetes from preconception to the postnatal period: summary of NICE guidance.
Management of diabetes from preconception to the postnatal period: summary of NICE guidance.
复制标题
DOI：
10.1136/bmj.39505.641273.ad
复制
发表时间：
2008-03-29
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
为什么要阅读这篇摘要？妊娠期糖尿病与妇女的风险(例如，流产、先兆子痫和早产的较高比率)以及对发育中的胎儿和婴儿的风险(例如，先天性畸形、巨大儿、产伤和围产期死亡率的较高比率)有关。1 2这篇文章总结了国家健康与临床卓越研究所(NICE)关于如何管理糖尿病及其并发症从孕前到出生后的最新指导。3建议基于对最佳可用证据的系统评价。当有最低限度的证据可用时，建议是基于指南制定小组对什么是良好实践的意见。关于BMJ的这篇文章的较长版本中有这些建议的证据水平。COM。
Why read this summary? Diabetes in pregnancy is associated with risks to the woman (for example, higher rates of miscarriage, preeclampsia, and preterm labour) and to the developing fetus and baby (for example, higher rates of congenital malformations, macrosomia, birth injury, and perinatal mortality). 1 2 This article summarises the most recent guidance from the National Institute for Health and Clinical Excellence (NICE) on how to manage diabetes and its complications from preconception to the postnatal period. 3Recommendations NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the guideline development group’s opinion of what constitutes good practice. Evidence levels for the recommendations are in the longer version of this article on bmj. com.